A U.K. woman, who was diagnosed with a rare cancer, recalls having eight organs removed in what she described as 'the mother ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

SHRA-1921 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Metastatic Breast Cancer.